High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant

Ploenchan ChetchotisakdSiriluck AnunnatsiriSasisopin KiertiburanakulRuengpung SutthentThanomsak AnekthananonChureeratana BowonwatanuwongBoonchai KowadisaiburanaKhuanchai SupparatpinyoManassinee HorsakulthaiSanchai ChasombatKiat RuxrungthamKhon Kaen UniversityMahidol UniversityChonburi Regional HospitalBamrasnaradura Infectious Disease InstituteChiang Mai UniversityThailand Ministry of Public HealthChulalongkorn UniversityThe HIV Netherlands Australia Thailand Research Collaboration2018-08-202018-08-202006-12-01Journal of the International Association of Physicians in AIDS Care. Vol.5, No.4 (2006), 152-15615570886154510972-s2.0-35448999929https://repository.li.mahidol.ac.th/handle/20.500.14594/23285The prevalence of drug resistance was determined among 64 HIV-infected Thai patients who were failed while receiving nonnucleoside reverse transcriptase inhibitor (NNRTI)-based regimens. Eighty-nine percent of patients had 1 or more NNRTI mutation resistances. Almost all patients had resistance to at least 1 nucleoside reverse transcriptase inhibitor (NRTI), and 42% had multiple-NRTI resistance. © 2006 Sage Publications.Mahidol UniversityImmunology and MicrobiologyMedicineHigh rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominantArticleSCOPUS10.1177/1545109706294288